Since 1964, Opocrin S.p.A. has made researching, manufacturing and marketing active pharmaceutical ingredients derived from animal organs and tissues its core business.
Previous PostOpocrin S.p.A. concludes the first sales of Heparin Sodium
Next PostOpocrin S.p.A. acquista una quota di maggioranza Omikron Italia s.r.l.
